{"name":"Calimmune, Inc.","slug":"calimmune-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cal-1 modified HSPC","genericName":"Cal-1 modified HSPC","slug":"cal-1-modified-hspc","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Cal-1 modified HSPC","genericName":"Cal-1 modified HSPC","slug":"cal-1-modified-hspc","phase":"phase_1","mechanism":"Genetically modified hematopoietic stem cells designed to provide HIV resistance through expression of anti-HIV genes.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQaVkwclNxS1hFTnplUzZRQXBBeGRqbkQ5Qms0X00tUzJBMURQOTlVN1VuN3czM3VyVGNiWVJCakhYMl9Ca3RBbElhUXRuNnBZU01lcTZQMEdFQnY2RnMwVTlrbW9WNDVwQmVlZ0xpY0xLOUkxdDRZRmFteGlIMFlqSXVDUVJHRDVLUl9oVzVvTU5rTHVLZHR4S05GWjBkeHdy?oc=5","date":"2021-07-11","type":"pipeline","source":"Los Angeles Business Journal","summary":"Incubators Nurture Local Bioscience Startups - Los Angeles Business Journal","headline":"Incubators Nurture Local Bioscience Startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFAzZDJrTzlkZzVjNDFtclBLOEZJUGs2QXBuX19sZnd4RFgyRUNIdDNoSzZ2MXdTRHVlTjI3akRiVFZGTjJXUjJNR3YtMzJ1WUhpQ3FJblNlS3hRdm9tbkFGOTJDWXIwWHRLNWsxT3BKOW5QUlVvYURsZnhfWQ?oc=5","date":"2018-08-07","type":"pipeline","source":"Bain & Company","summary":"Global Healthcare Corporate M&A 2018 - Bain & Company","headline":"Global Healthcare Corporate M&A 2018 - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxObVpNWUhXaXJCSlhMYU0zNW8tMHV3eUtLanA0R3pKZkREeTJQbm9jenFJWENVNElNTGY5N1otUTZaWWdZRHV5dkgwWFE5SzVGeWEyalpQLVZxd3drWm9lbGV1N0c4WEM3LWdPaWM0OURqYW9oaWhha1E1RmlFZ1FkdTdCNk13RHpRVXFoNDB0Y3Z3NHhwQ0ZuckZQQXdKZ05mTnNCTC1xd1pvWWJHSXBlb3lKTVB4cjNkQUFZN2ZKUDZQM1phT29FeUs4YXh6aG84cFpfa3BqWEFJb3RXV0FVTG1HT3I4b3JrSEZrNw?oc=5","date":"2017-08-28","type":"deal","source":"prnewswire.com","summary":"CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform - prnewswire.com","headline":"CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}